Radiotherapy update from CTRad
Now in its sixth year, and with a new block of funding agreed until 2018, our radiotherapy initiative, CTRad, is going strong. Its recent activities to boost radiotherapy research include a researchers’ sandpit day, a workshop to scope ideas for Cancer Research UK’s Grand Challenge and a proton beam therapy research town meeting. More information about the recent activities within CTRad can be found in the CTRad bulletin.
In addition, there have been some recent rotations in membership of CTRad, in keeping with the membership terms, and to ensure there is a balance between retaining valuable expertise and new members, particularly in niche areas. In terms of leadership, four of the eight Workstream co-chair roles have new appointments from 1 June. These are:
- Workstream 1 (Science base): Prof Susan Short (taking over from Prof Kevin Harrington)
- Workstream 2 (Phase I/II trials): Dr Richard Adams (taking over from Prof Ruth Plummer)
- Workstream 3 (Phase III trials and methodology): Prof David Sebag-Montefiore (taking over from Prof Chris Nutting)
- Workstream 4 (New technology, physics and quality assurance): Dr Philip Evans (taking over from Dr Ranald Mackay)
RaDCom invites proposals for radiotherapy-drug combination projects
The Radiotherapy-Drug Combinations Consortium (RaDCom) invites investigators to contact RaDCom’s steering group to discuss proposals for radiotherapy-drug combination projects. RaDCom is keen to hear from investigators with ideas for suitable projects, or laboratories with expertise and/or facilities to offer.